Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness

INTRODUCTION: There is uncertainty about whether cytoreductive surgery (CRS)+hyperthermic intraoperative peritoneal chemotherapy (HIPEC) improves survival and/or quality of life compared with standard of care (SoC) in people with peritoneal metastases who can withstand major surgery. PRIMARY OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurusamy, Kurinchi, Vale, Claire L, Pizzo, Elena, Bhanot, R, Davidson, Brian R, Mould, Tim, Mughal, Muntzer, Saunders, Mark, Aziz, Omer, O'Dwyer, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228534/
https://www.ncbi.nlm.nih.gov/pubmed/32404398
http://dx.doi.org/10.1136/bmjopen-2020-039314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228534/
https://www.ncbi.nlm.nih.gov/pubmed/32404398
http://dx.doi.org/10.1136/bmjopen-2020-039314

Ejemplares similares